Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
02 Agosto 2023 - 10:05PM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage
biotechnology company with a mission to discover, develop and
deliver potentially curative therapies that address the underlying
causes of heart disease, today announced that Tenaya senior
management will participate in the 43rd Annual Canaccord Genuity
Growth Conference taking place in Boston. Details of participation
are as follows:
Tenaya Therapeutics Company Presentation Date:
August 9, 2023 Time: 8:00 AM PT / 11:00 AM ET
A webcast of the presentation will be available
for approximately 90 days by visiting the Investors section of
Tenaya’s website.
About Tenaya Therapeutics Tenaya
Therapeutics is a clinical-stage biotechnology company committed to
a bold mission: to discover, develop and deliver potentially
curative therapies that address the underlying drivers of heart
disease. Leveraging its integrated and interrelated Gene Therapy,
Cellular Regeneration and Precision Medicine platforms and
proprietary core capabilities, the company is advancing a pipeline
of novel therapies with diverse treatment modalities for rare
genetic cardiovascular disorders and more prevalent heart
conditions. Tenaya’s most advanced candidates include TN-201, a
gene therapy for MYBPC3-associated hypertrophic cardiomyopathy
(HCM), TN-401, a gene therapy for PKP2-associated arrhythmogenic
right ventricular cardiomyopathy (ARVC), and TN-301, a small
molecule HDAC6 inhibitor being initially developed for heart
failure with preserved ejection fraction (HFpEF). Tenaya also has
multiple early-stage programs progressing through preclinical
development. For more information, visit
www.tenayatherapeutics.com.
Contacts
Investors Michelle Corral Vice
President, Investor Relations and Corporate Communications Tenaya
Therapeutics IR@tenayathera.com
Media Wendy Ryan Ten Bridge
Communications wendy@tenbridgecommunications.com
Grafico Azioni Tenaya Therapeutics (NASDAQ:TNYA)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Tenaya Therapeutics (NASDAQ:TNYA)
Storico
Da Set 2023 a Set 2024